Key Clinical Investigators

Our key clinical investigators are those directly involved in the ongoing and forthcoming clinical trials in Autoimmunity/Inflammation. Leaders include those who specialise in Lupus and CIDP.

Professor David Isenberg 

Prof. Isenberg’s principal clinical interests have been in the development of disease activity and damage assessment tools in patients with lupus. Chair of the British Isles Assessment Group and also the Chair (1998-2003) of the Systemic Lupus International Collaborating Clinics group (SLICC). He is the Professor of Rheumatology, University College Hospital, London.

Read more..

Professor Jérôme de Sèze

Head of the Neuroimmunological Department, University of Strasbourg, FR Program: CIDP ((Chronic Inflammatory Demyelinating Polyneuropathy)

Professor De Seze has been instrumental in guiding the development of our Phase 2/3 adaptive clinical trial in CIDP. This will be a pivotal trial suitable for registration. Next steps are the IND submission to the FDA and an application for orphan drug designation. We would expect to commence this trial in 2023.

Read more..